| Cat.No. | Name | Information |
|---|---|---|
| M44945 | N-Benzyllinolenamide | N-Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM. |
| M18241 | N-Benzylpalmitamide | N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). |
| M14425 | LY2183240 | LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. |
| M9271 | BIA 10-2474 | BIA 10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH). |
| M8950 | JNJ-42165279 | JNJ-42165279 is a potent and selective FAAH inhibitor with IC50s of 70 ± 8 nM and 313 ± 28 nM for hFAAH and rFAAH, respectively. |
| M7115 | PF 04457845 | PF 04457845 is a potent and selective irreversible FAAH inhibitor. |
| M6169 | FAAH-IN-2 | FAAH-IN-2 is a potent FAAH (fatty acid amide hydrolase) inhibitor. |
| M4693 | Biochanin-A | Biochanin A is A naturally occurring fatty acid amide hydrolase (FAAH) inhibitor that inhibits FAAH in mice, rats and humans with FAAH IC50 of 1.8, 1.4 and 2.4 μM, respectively. |
| M3525 | PF-3845 | PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2. |
| M3404 | URB597 | URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. |
| M2783 | JNJ-1661010 | JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2. |
| M56684 | JP104 | JP104, a aryl carbamate, is an irreversible FAAH inhibitor with a pIC50 of ~8. |
| M56683 | AM1172 | AM1172 is metabolically stable anandamide uptake inhibitor and FAAH inhibitor. |
| M56682 | URB937 | URB937 is an orally active and peripherally restricted FAAH inhibitor (IC50=26.8 nM) and increases anandamide levels. |
| M56681 | JNJ-40355003 | JNJ-40355003 is a potent and selective atty acid amide hydrolase (FAAH) inhibitor. |
| M44941 | N-(3-Methoxybenzyl)palmitamide | N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders. |
| M42393 | VU534 | VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.In addition, VU534 can dependently enhance Efferocytosis in macrophages. VU534 can be used in studies of cardiometabolic diseases. |
| M27945 | MK-4409 | MK-4409 is a potent oxazole FAAH inhibitor and can be used for the research of inflammatory and neuropathic pain. |
| M14426 | URB-597 | URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
